Published in

Elsevier, Journal of Hepatology, (77), p. S376, 2022

DOI: 10.1016/s0168-8278(22)01104-7

Wiley, Hepatology, 4(76), p. 1000-1012, 2022

DOI: 10.1002/hep.32468

Links

Tools

Export citation

Search in Google Scholar

Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child‐Pugh A and B cirrhosis: A real‐world study

Journal article published in 2022 by Johann von Felden, Brooke Wietharn, Linda Wu, Antonio D’Alessio ORCID, Claudia Angela Maria Fulgenzi, Naoshi Nishida, Martin Schönlein ORCID, Kornelius Schulze, Henning Wege, Vincent E. Gaillard, Claudia Angela Maria Fulgenzi, Arndt Weinmann, Anwaar Saeed, Peter R. Galle, Hannah Hildebrand and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO